RSS Feeds


Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 182 - per page Next page
Order by
Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More
25 and 50 mg diclofenac K film coated immediate release tablets More
Topical Diclofenac formulations for the treatment of inflammatory and painful conditions More
Adhesive Patch of 90 sq. cm. and containing as active ingredient 100 mg. of ketoprofen for the local treatment of traumatic injuries and extra-articular rheumatism More
Capsaicin, the active ingredient found in red-hot peppers, is used mainly for the relief of chronic pain of rheumatoid arthritis and osteoarthritis More
25mg dosage strenght for the OTC market in film coated tablets More
The First Line of Therapy in Severe Migraine Attacks More
25mg dosage strenght for the OTC market More
The first pure, immediate release (Tmax in 13,68 min), completely palatable and free from aftertaste diclofenac potassium formulation in drops at 5% available on the market More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Displaying 1..10 of 182 - per page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2014 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us